23-Jan-2019 | Zion Market Research
Zion Market Research has published a new report titled “Structural Heart Devices Market by Product Type (Heart Valve Devices, Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), by Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD), and Aortic Valve Stenosis), and by End-User (Hospitals, Ambulatory Surgical Centers, and others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019—2025”. According to the report, the global structural heart devices market was valued at approximately USD 8,858 million in 2018 and is expected to generate around USD 17,152 million by 2025, at a CAGR of around 9.9% between 2019 and 2025.
Structural heart devices are used to maintain the normal structure of a human heart. Due to the various congenital defects and cardiovascular infections, heart muscles lose their shape. This, in turn, affects the normal functioning of the heart. Common heart structural diseases include atrial septal defects, patient foramen ovale, Paravalvular leak, etc. These devices can be placed through minimally invasive procedures, whereas a few cases need open heart surgery. Minimally invasive surgeries have reduced the risk and decreased the recovery time.
Browse the full “Structural Heart Devices Market by Product Type (Heart Valve Devices, Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), by Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD), and Aortic Valve Stenosis), and by End-User (Hospitals, Ambulatory Surgical Centers, and others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019—2025” Report at https://www.zionmarketresearch.com/report/structural-heart-devices-market
One of the major factors likely to drive the structural heart devices market globally in the future is the constant increase in the prevalence of congenital heart defects. As per the Centers for Disease Control and Prevention 2018 report, there were around 40,000 infants diagnosed with congenital heart defects in the U.S. Moreover, there is a constant increase in the demand of minimally invasive surgeries coupled with an increased recovery rate. Furthermore, substantial increase related to technological advancements and research and development activities has resulted in the introduction of innovative products, thereby promoting the structural heart devices market growth in the future. However, the high cost of these devices and the enforcement of stringent legislation governing the approval of new devices might hamper the structural heart devices market over the estimated time span.
The global structural heart devices market is classified on the basis of product type, indication, and end-user. By product type, the structural heart devices market includes heart valve devices, occluders, and delivery systems, annuloplasty rings, and accessories. Heart valve devices are expected to dominate the structural heart devices market in the upcoming years. By indication, the structural heart devices market is segmented into atrial septal defect (ASD), patent foramen ovale (PFO), ventricular septal defect (VSD), and aortic valve stenosis. By end-user, the structural heart devices market is segmented into hospitals, ambulatory surgical centers, and others.
By region, the global structural heart devices market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to lead the structural heart devices market globally over the forecast time period, followed by Europe. The Asia Pacific region is projected to be the fastest growing region over the estimated timeframe, owing to the significant contributions made by developing economies, such as India and China. The Latin American and the Middle Eastern and African markets are anticipated to grow moderately in the future.
Some major market players of the global structural heart devices include Abbott Laboratories, Medtronic Plc., Endologix Inc., LivaNova Plc., Boston Scientific Corporation, CryoLife Inc., Cook Group Incorporated, Edwards Lifesciences Corporation, and W. L. Gore & Associates, Inc., among others.
This report segments the global structural heart devices market into:
Global Structural Heart Devices Market: Product Type Analysis
Global Structural Heart Devices Market: Indication Analysis
Global Structural Heart Devices Market: End-User Analysis
Global Structural Heart Devices Market: Regional Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651